Blood-testing startup Theranos says it is shutting down its facilities and laying off about 340 employees.
In a statement to stakeholders, CEO Elizabeth Holmes says the company will focus on rebuilding after several investigations into its practices.
The Palo Alto-based company developed what it claimed was the first blood test that could diagnose diseases from a single drop of blood.
